Inventor · disambiguated record
Linghang Zhuang
Also filed as: ZHUANG LINGHANG · ZHUANG LINGHANG H
65 granted patents·23 pending applications·407 citations·filing 1999–2025
98Inventor score
Files withVITAE PHARMACEUTICALS INC20VITAE PHARMACEUTICALS LLC19CLAREMON DAVID A17MERCK & CO INC8ETERNITY BIOSCIENCE INC7
Top patents by PatentIndex Score
88 records- 0195US11479557B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Oct 25, 2022·4 cites·23 claims
- 0295US9663515B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2015·Granted May 30, 2017·13 cites·15 claims
- 0395US8242111B2Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Aug 14, 2012·36 cites·24 claims
- 0495US8138178B2Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Mar 20, 2012·37 cites·24 claims
- 0594US10047085B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2017·Granted Aug 14, 2018·14 cites·20 claims
- 0694US9624217B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Apr 18, 2017·14 cites·22 claims
- 0793US10399976B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2018·Granted Sep 3, 2019·11 cites·20 claims
- 0893US9868748B2Thiazolopyrrolidine inhibitors of ROR- γVITAE PHARMACEUTICALS INC·Filed 2014·Granted Jan 16, 2018·13 cites·19 claims
- 0993US9796710B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Oct 24, 2017·12 cites·14 claims
- 1092US10087184B2Dihydropyrrolopyridine inhibitors of RORγVITAE PHARMACEUTICALS INC·Filed 2017·Granted Oct 2, 2018·10 cites·13 claims
- 1192US8202857B21,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Jun 19, 2012·21 cites·75 claims
- 1291US12312359B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2022·Granted May 27, 2025·1 cites·15 claims
- 1391US10683302B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jun 16, 2020·9 cites·28 claims
- 1491US8440658B2Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2008·Granted May 14, 2013·16 cites·19 claims
- 1588US10899758B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jan 26, 2021·6 cites·25 claims
- 1688US10301261B2Substituted indoles as modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2016·Granted May 28, 2019·6 cites·22 claims
- 1788US6921759B2Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitorsMERCK & CO INC·Filed 2001·Granted Jul 26, 2005·41 cites·23 claims
- 1888US6380249B1HIV integrase inhibitorsMERCK & CO INC·Filed 1999·Granted Apr 30, 2002·51 cites·21 claims
- 1987US10807980B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2019·Granted Oct 20, 2020·4 cites·20 claims
- 2086US11535614B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Dec 27, 2022·1 cites·20 claims
- 2186US9416135B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2015·Granted Aug 16, 2016·4 cites·27 claims
- 2286US9073931B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2013·Granted Jul 7, 2015·5 cites·3 claims
- 2386US9006245B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2014·Granted Apr 14, 2015·5 cites·9 claims
- 2485US11739085B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Aug 29, 2023·1 cites·21 claims
- 2584US9006244B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2013·Granted Apr 14, 2015·5 cites·49 claims
- 2683US8575156B2Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2008·Granted Nov 5, 2013·5 cites·20 claims
- 2782US10829448B2Substituted benzoimidazoles as modulators of ROR-γVITAE PHARMACEUTICALS LLC·Filed 2019·Granted Nov 10, 2020·1 cites·6 claims
- 2882US8569292B2Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Oct 29, 2013·5 cites·7 claims
- 2980US9845308B2Isoindoline inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2015·Granted Dec 19, 2017·2 cites·12 claims
- 3080US8598160B2Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Dec 3, 2013·4 cites·15 claims
- 3180US8592410B2Cyclic inhibitors of 11BETA-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Nov 26, 2013·4 cites·10 claims
- 3280US8497281B2Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinolineECKHARDT MATTHIAS·Filed 2010·Granted Jul 30, 2013·4 cites·35 claims
- 3380US7598264B2HIV integrase inhibitorsMERCK & CO INC·Filed 2005·Granted Oct 6, 2009·7 cites·11 claims
- 3480US7538112B2HIV integrase inhibitorsMERCK & CO INC·Filed 2005·Granted May 26, 2009·3 cites·13 claims
- 3579US11001583B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2019·Granted May 11, 2021·1 cites·11 claims
- 3678US8680281B2Lactam inhibitors of 11-β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Mar 25, 2014·3 cites·15 claims
- 3778US2025326764A1Inhibitors of the menin-mll interactionVITAE PHARMACEUTICALS LLC·Filed 2025·Application pending·0 cites
- 3877US10829481B2Benzimidazole derivatives as modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Nov 10, 2020·1 cites·22 claims
- 3977US8673899B2Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2012·Granted Mar 18, 2014·3 cites·22 claims
- 4076US8598163B2Derivatives of [1,3]Oxazin-2-one useful for the treatment of metabolic diseases such as lipid disordersCLAREMON DAVID·Filed 2010·Granted Dec 3, 2013·6 cites·30 claims
- 4176US7820680B2HIV integrase inhibitorsMERCK & CO INC·Filed 2005·Granted Oct 26, 2010·1 cites·12 claims
- 4275US9707232B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2016·Granted Jul 18, 2017·1 cites·19 claims
- 4375US2024124447A1Inhibitors of the menin-mll interactionVITAE PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 4473US11535633B2Fused tricyclic heterocycle compounds and therapeutic uses thereofJIANGSU HENGRUI MEDICINE CO·Filed 2019·Granted Dec 27, 2022·2 cites·33 claims
- 4573US8399504B2Carbamate and urea inhibitors of 11Beta-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Mar 19, 2013·1 cites·24 claims
- 4672US11008340B2Modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2016·Granted May 18, 2021·1 cites·14 claims
- 4772US9388190B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2015·Granted Jul 12, 2016·1 cites·16 claims
- 4872US8846668B2Inhibitors of 11beta-hydroxysteroid dehydrogenase 1HIMMELSBACH FRANK·Filed 2009·Granted Sep 30, 2014·1 cites·6 claims
- 4971US9328072B2Aryl-and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinolineECKHARDT MATTHIAS·Filed 2013·Granted May 3, 2016·1 cites·34 claims
- 5067US8927539B2Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structureCLAREMON DAVID A·Filed 2010·Granted Jan 6, 2015·1 cites·15 claims
Showing the top 50 of 88 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Linghang Zhuang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →